RxDoctor Payments Data

Jennifer Hathaway, NP

Nurse Practitioner · Castle Rock, CONPI 1467957555

Payments from drug & device makers

$1,516in general payments, 2019–2025

Across 73 payments — averaging $20.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$295
  • AbbVie$187
  • Medtronic$181
  • Novo Nordisk$124
  • Astellas Pharma US Inc$121
  • Lilly USA, LLC$72
  • plus $534 from 17 others

What the payments were for

  • Food & beverage$1,50499%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,516 in reported general payments places this provider in the 85th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado

Medicare billing

Part B allowed, 2024
$32,187
Medicare patients
124
Services billed
507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide43$80,023
EliquisApixaban23$34,670
FarxigaDapagliflozin Propanediol12$18,959
MounjaroTirzepatide12$15,078
Spiriva RespimatTiotropium Bromide12$6,505
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$4,376
VyvanseLisdexamfetamine Dimesylate11$4,304
Levothyroxine Sodium193$1,773
YuvafemEstradiol13$1,570
Atorvastatin Calcium153$1,511
SynthroidLevothyroxine Sodium26$1,490
Gabapentin77$1,445
Rosuvastatin Calcium77$1,409
Estradiol24$1,100
Estradiol (Twice Weekly)Estradiol11$1,096

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$124$80,02343 claims
PfizerEliquis$69$34,67023 claims
AstraZenecaFarxiga$295$18,95912 claims
Lilly USA, LLCMounjaro$72$15,07812 claims
AbbVieSynthroid$187$1,49026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,384 nurse practitioner providers in Colorado.

Other nurse practitioner in Castle Rock

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →